anserine has been researched along with Obesity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baelde, H; Derave, W; Everaert, I; Hanssens, M; Stautemas, J; van Aanhold, C; Van der Stede, T; Vanhaecke, L | 1 |
1 other study(ies) available for anserine and Obesity
| Article | Year |
|---|---|
Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice.
Topics: Administration, Oral; Animals; Anserine; Blood Glucose; Carnosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Limit of Detection; Mice; Obesity | 2021 |